(Q43660041)

25 November 2017

Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost (English)

1 reference

25 November 2017

DuBiner H

1

1 reference

25 November 2017

Cooke D

2

1 reference

25 November 2017

Dirks M

3

1 reference

25 November 2017

Stewart WC

4

1 reference

25 November 2017

VanDenburgh AM

5

1 reference

25 November 2017

Felix C

6

1 reference

25 November 2017

1 May 2001

1 reference

25 November 2017

Survey of Ophthalmology

1 reference

25 November 2017

45 Suppl 4

1 reference

25 November 2017

S353-60

1 reference

Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900212-0

7 January 2021

Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900212-0

7 January 2021

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900212-0

7 January 2021

Rank Transformations as a Bridge Between Parametric and Nonparametric Statistics

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900212-0

7 January 2021

Fluctuations of intraocular pressure during the day in open-angle glaucoma, normal-tension glaucoma and normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900212-0

7 January 2021

Intraocular pressure-dependent progression of visual field loss in advanced primary open-angle glaucoma: a 15-year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900212-0

7 January 2021

Target pressure--glaucomatologists' holey grail.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900212-0

7 January 2021

The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900212-0

7 January 2021

Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900212-0

7 January 2021

Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2801%2900212-0

7 January 2021

10.1016/S0039-6257(01)00212-0

Identifiers

DOI

1 reference

25 November 2017

1 reference